The results showed that the expression of PCBP1-AS1, FAM222A, FHAD1, WDR62, and SBK1 was significantly correlated with tumor clinical stage, pathologic TNM, and lymphatic invasion (p < 0.05) (Figure 4C). Here, FAM222A is linked to neoplasm.